These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12744193)

  • 1. [Mechanism of priming cytotoxic T cell response and strategy for enhancing DNA vaccine potency in DNA immunization].
    Deng X; Cai M
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Mar; 20(1):175-9. PubMed ID: 12744193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Priming of CTL responses by DNA vaccines: direct transfection of antigen presenting cells versus cross-priming.
    Ulmer JB; Otten GR
    Dev Biol (Basel); 2000; 104():9-14. PubMed ID: 11713829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting dendritic cells to enhance DNA vaccine potency.
    You Z; Huang X; Hester J; Toh HC; Chen SY
    Cancer Res; 2001 May; 61(9):3704-11. PubMed ID: 11325842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving DNA vaccine potency via modification of professional antigen presenting cells.
    Hung CF; Wu TC
    Curr Opin Mol Ther; 2003 Feb; 5(1):20-4. PubMed ID: 12669466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modifying professional antigen-presenting cells to enhance DNA vaccine potency.
    Hung CF; Yang M; Wu TC
    Methods Mol Med; 2006; 127():199-220. PubMed ID: 16988456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting antigen to MHC Class I and Class II antigen presentation pathways for malaria DNA vaccines.
    Dobaño C; Rogers WO; Gowda K; Doolan DL
    Immunol Lett; 2007 Aug; 111(2):92-102. PubMed ID: 17604849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virosomes for antigen and DNA delivery.
    Daemen T; de Mare A; Bungener L; de Jonge J; Huckriede A; Wilschut J
    Adv Drug Deliv Rev; 2005 Jan; 57(3):451-63. PubMed ID: 15560951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen presentation and DNA vaccines.
    Donnelly JJ; Liu MA; Ulmer JB
    Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 2):S190-3. PubMed ID: 11029393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA gene fusion vaccines against cancer.
    Zhu D; Stevenson FK
    Curr Opin Mol Ther; 2002 Feb; 4(1):41-8. PubMed ID: 11883694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting plasmid-encoded proteins to the antigen presentation pathways.
    Leifert JA; Rodriguez-Carreno MP; Rodriguez F; Whitton JL
    Immunol Rev; 2004 Jun; 199():40-53. PubMed ID: 15233725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoplasmic reticulum targeting sequence enhances HBV-specific cytotoxic T lymphocytes induced by a CTL epitope-based DNA vaccine.
    Xu W; Chu Y; Zhang R; Xu H; Wang Y; Xiong S
    Virology; 2005 Apr; 334(2):255-63. PubMed ID: 15780875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of HPV-16 E6 DNA vaccines employing intracellular targeting and intercellular spreading strategies.
    Peng S; Trimble C; Ji H; He L; Tsai YC; Macaes B; Hung CF; Wu TC
    J Biomed Sci; 2005 Oct; 12(5):689-700. PubMed ID: 16200349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epitope DNA vaccines against tuberculosis: spacers and ubiquitin modulates cellular immune responses elicited by epitope DNA vaccine.
    Wang QM; Sun SH; Hu ZL; Zhou FJ; Yin M; Xiao CJ; Zhang JC
    Scand J Immunol; 2004 Sep; 60(3):219-25. PubMed ID: 15320877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced CTL response by controlled intracellular trafficking of antigen in dendritic cells following DNA vaccination.
    Isaji K; Kawase A; Matono M; Guan X; Nishikawa M; Takakura Y
    J Control Release; 2009 May; 135(3):227-33. PubMed ID: 19331843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an antigen-presenting cell-targeted DNA vaccine against melanoma by mannosylated liposomes.
    Lu Y; Kawakami S; Yamashita F; Hashida M
    Biomaterials; 2007 Jul; 28(21):3255-62. PubMed ID: 17449093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA vaccines increase immunogenicity of idiotypic tumor antigen by targeting novel fusion proteins to antigen-presenting cells.
    Fredriksen AB; Sandlie I; Bogen B
    Mol Ther; 2006 Apr; 13(4):776-85. PubMed ID: 16414309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic analysis of augmented immune responses in mouse by prime-and-boost immunization strategy with DNA vaccine coding HBsAg and rHBsAg protein.
    Wang Y; Li DA; Hey Y; Wang F; Guo YJ; Yang F; Zhou Q; Sun SH
    Vaccine; 2007 Nov; 25(48):8146-53. PubMed ID: 18029065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-immunisation with DNA encoding RANK/RANKL or 4-1BBL costimulatory molecules does not enhance effector or memory CTL responses afforded by immunisation with a tumour antigen-encoding DNA vaccine.
    Herd KA; Wiethe C; Tindle RW
    Vaccine; 2007 Jul; 25(28):5209-19. PubMed ID: 17544551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A DNA vaccine encoding a codon-optimized human papillomavirus type 16 E6 gene enhances CTL response and anti-tumor activity.
    Lin CT; Tsai YC; He L; Calizo R; Chou HH; Chang TC; Soong YK; Hung CF; Lai CH
    J Biomed Sci; 2006 Jul; 13(4):481-8. PubMed ID: 16649071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New understanding of immunological mechanisms.
    Saalmüller A
    Vet Microbiol; 2006 Oct; 117(1):32-8. PubMed ID: 16701965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.